Q2 FY2026 · ended Jun 30, 2026 · Revenue $414,000, +30.6% YoY · Filed Aug 13, 2026
Harvard Apparatus Regenerative Technology, Inc. (HRGN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $414,000 and a net loss of $1.7 million. As of Jun 30, 2026 it held $351,000 in cash and investments and $145,000 in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- HRGN (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Holliston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1563665
- Former names
- Biostage, Inc. (until Jul 10, 2023)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $414,000 | $226,000 | $219,000 | $123,000 | $317,000 |
| Operating income | -$1.7M | -$1.6M | -$1.7M | -$1.7M | -$1.8M |
| Net income | -$1.7M | -$1.6M | -$1.7M | -$1.7M | -$1.8M |
| Operating cash flow | -$569,000 | -$937,000 | -$664,000 | -$1.5M | -$941,000 |
| Total assets | $1.7M | $1.8M | $2.7M | $2.5M | $2.1M |
| Total liabilities | $3.1M | $1.7M | $1.6M | $992,000 | $1.4M |
| Stockholders' equity | -$1.4M | $92,000 | $1.1M | $1.6M | $761,000 |
| Cash and investments | $351,000 | $419,000 | $1.4M | $1.3M | $786,000 |
| Total debt | $145,000 | $173,000 | $199,000 | $224,000 | $249,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 14, 2026 | Sep 11, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 3, 2026 | May 8, 2026 |
| 8-K/A |
Amended current report
Material agreement, New debt
|
Aug 3, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 18, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 625 Harvard Apparatus Regenerative Technology, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.